Lex Witness – India’s 1st Magazine on Legal & Corporate Affairs successfully completed its 8th Annual Pharma Legal & Compliance Summit 2019 on 11th October 2019 at Four Seasons Hotel, Mumbai. With over 30 industry veterans as Speakers and 100 delegates from Pharma sector, the summit proved out to be a commendable knowledge base for the industry.
There is no doubt in ascertaining that the Pharmaceuticals space has been rocketing at a lightning speed globally as far growth and innovation patterns are concerned. And the space not only limits itself to drugs, one can of course not put aside the massive medical devices, biosimilars, healthcare and the world of medicines on the internet! And as always, India leaps a very sharp and directed approach.
As per a story in Firstpost titled “Where is India’s pharma market headed? Regulatory infrastructure must be put in place to ensure global quality”, an evaluation of Rs 1.1 lakh crore (FY 2017) and a global market share of 20 percent speaks volumes about our place in the global market. The Indian pharmaceutical market (IPM) is expected to grow at 9-12 percent compound annual growth rate (CAGR) between 2016-21.
The story further elaborates that Indian drug are failing at the World Health Organisation (WHO) quality standards and those required by the western drug regulating authorities like the Food and Drug Administration (FDA). It was not too long ago that the USFDA had found deficiencies relating to medicine quality in India. The ‘Special 301 Report’ by the United States Trade Representatives (USTR) slammed India and China as leading sources of counterfeit medicines distributed globally with 20 percent of all pharmaceutical products sold in the Indian market is estimated to be counterfeit.
These and several other aspects brought together legal and regulatory experts once again to brainstorm on the issues in hand and spear forth with a perfect compliance score in hand.
Amit Thukral, Vice President – Legal, Lupin – MODERATOR
Amit Bansal, Partner – Forensic, Financial Advisory, Deloitte India
Himanshu Ranvah, Head Legal, Macleods Pharmaceuticals
Jidesh Kumar, Managing Partner, King Stubb & Kasiva, Advocates & Attorneys
Raghunath Rath, AVP – Legal & Compliance and Company Secretary, Par India Operations
Subodh P. Deo, Partner, Saikrishna & Associates
Himanshu Ranvah, Head Legal, Macleods Pharmaceuticals – MODERATOR
Krishna Venkat, Partner, Anoma Legal
Ashish Prasad, Partner, Economic Laws Practice
Namrta Sudan, Partner, Dhir & Dhir Associates
Vivek Mittal, Regional Counsel – METAI Region, Danaher Corporation
Rakesh Sinha, Head Legal – Sun Pharmaceutical Industries
Swati Veera, Sr. GM & Sr. In-House Patent Attorney, Indoco Remedies – MODERATOR
Dr. Amit Bharam, Head – Intellectual Property and Legal Counsel, (Global), Mega Lifesciences
Bejoy Namath, Global IP litigation, Business Intelligence and IP Management-US, APAC, UPL
Mukund Thakkar, Senior Vice President – Legal, Zydus Cadila Group
Dhiroj Barad, Head Legal & Company Secretary, Siemens Healthineers – MODERATOR
K.P.S Kohli, Partner, Dhir and Dhir Associates
Deepa Bhandare, Compliance Officer — Healthcare Business, India & Emerging Frontier Markets, Merck India
Ashish Prasad, Partner, Economic Laws Practice
Abhishek Malhotra, Managing Partner, TMT Law Practice
Anushree Yewale, Senior Associate, TMT Law Practice
Prashant N Laghate, Director – Overseas Operations, Merck Specialities
Aakanshka Upadhya, Executive Legal, Emcure Pharmaceuticals
www.grandmasters.in | 8 Years & Counting
www.rcls.in | 8 Years & Counting
www.itlegalsummit.com | 8 Years & Counting
www.bfls.in | 8 Years & Counting
www.maels.in | 8 Years & Counting
www.plcs.co.in | 8 Years & Counting
Copyright © 2020 Lex Witness - India's 1st Magazine on Legal & Corporate Affairs Rights of Admission Reserved
